Applied Clinical Trials Online

Utilizing Tech Tools to Accelerate Drug Development

In contrast, by utilizing technology-driven tools more effectively, we can drive efficiencies, improve communication, and ...

Immunosuppressants API Market Research Report 2025 - Global $4.44 Bn Industry Trends, Opportunities, and Forecasts, 2020-2030F

The Immunosuppressants API market offers significant growth potential driven by increasing prevalence of autoimmune diseases ...

Join Apeloa at CPHI Frankfurt to Explore Advanced Technology & Integrated Solutions (Booth 9.1B64)

Empowering Next-Gen Bioconjugates (ADCs/XDCs): Apeloa provides high-purity linkers and comprehensive chemistry services to accelerate your ADC, targeted conjugation, and peptide drug development ...

Plant-based Active Pharmaceutical Ingredients Strategic Business Report 2025 | Global Plant-Based API Market to Reach $46.6 Billion by 2030

The plant-based API market is primed for growth due to heightened demand for sustainable, natural therapeutics and regulatory acceptance. Advances in extraction and purification improve reliability ...
Morningstar

Semaglutide API Delivery Enables Start of Lab-Scale ODF Development at BioNxt

VANCOUVER, BC / ACCESS Newswire / September 2, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:XPHYF)(FSE:4XT) is pleased to announce the receipt of the Semaglutide active ...
Business Wire

Alliance Pharma and Drug Development Solutions Are Now Resolian

MALVERN, Pa.--(BUSINESS WIRE)--Alliance Pharma, a global leader providing bioanalytical, DMPK, and CMC testing services in the pharmaceutical and biopharmaceutical industry, and Drug Development ...
Morningstar

BioNxt Solutions Introduces Targeted Chemotherapy Drug Delivery Platform for Precision Oncology

VANCOUVER, BC / ACCESS Newswire / July 8, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a development-stage biopharmaceutical company specializing in ...
abc27

Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengthen U.S. Drug Supply Resilience

EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.
News Medical

Malvern Panalytical expands pharmaceutical drug development solutions through the acquisition of Creoptix

Malvern Panalytical, a company providing advanced analysis and services solutions for the pharma drug product development, as well as services and solutions for other industries, has today announced ...
GEN

Thermo Fisher-Tufts Study Links CRO-CDMO Platform to Shorter Cancer Drug Development Timeframe

Thermo Fisher Scientific says addressing the need for prefilled syringes is among potential production bottlenecks, the company is working to address. Thermo Fisher’s Accelerator™ Drug Development ...

Indian drugmaker Divi's beats profit view for second quarter on API boost

(Reuters) -Indian drugmaker Divi's Laboratories reported second-quarter profit above analysts' estimates on Friday, helped by its business that focuses on customised production of chemical compounds ...